Albrecht Stenzinger

Active 2009–2025

260
Papers
25,435
Citations
80
h-index
238
i10-index

Citations

Citations per year for Albrecht Stenzinger1945: 1 citations1977: 2 citations1986: 1 citations1996: 1 citations1999: 2 citations2000: 1 citations2003: 1 citations2004: 2 citations2007: 1 citations2010: 2 citations2011: 3 citations2012: 14 citations2013: 47 citations2014: 99 citations2015: 132 citations2016: 127 citations2017: 135 citations2018: 133 citations2019: 631 citations2020: 1,010 citations2021: 1,565 citations2022: 1,549 citations2023: 1,190 citations2024: 1,941 citations2025: 981 citations2026: 35 citations1946–1976: no citations, so these years are not shown1978–1985: no citations, so these years are not shown1987–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown2001–2002: no citations, so these years are not shown2005–2006: no citations, so these years are not shown2008–2009: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,634 citing papers, 18.5% of this breakdownChina: 1,892 citing papers, 13.3% of this breakdownGermany: 1,386 citing papers, 9.7% of this breakdownUnited Kingdom: 830 citing papers, 5.8% of this breakdownItaly: 816 citing papers, 5.7% of this breakdownFrance: 607 citing papers, 4.3% of this breakdownSpain: 473 citing papers, 3.3% of this breakdownNetherlands: 457 citing papers, 3.2% of this breakdownJapan: 434 citing papers, 3% of this breakdownCanada: 421 citing papers, 3% of this breakdownSwitzerland: 369 citing papers, 2.6% of this breakdownAustralia: 308 citing papers, 2.2% of this breakdown
0%18.5%Other 25.4%

Fields

  • Medicine66.6%
  • Biochemistry, Genetics and Molecular Biology22.9%
  • Computer Science4.4%
  • Immunology and Microbiology2.6%
  • Chemistry1.2%
  • Engineering0.9%
  • Other1.4%

Topics

  • Cancer Genomics and Diagnostics7.2%
  • Cancer Immunotherapy and Biomarkers6.8%
  • Lung Cancer Treatments and Mutations4.5%
  • Cancer Cells and Metastasis2.6%
  • Ferroptosis and cancer prognosis2.5%
  • Radiomics and Machine Learning in Medical Imaging2.4%
  • Other74%

Coauthors

All papers

Open in search
  1. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

    Authors: , , , , , , - Annals of Oncology 2018 cited by 2,884

  2. Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

    Authors: , , , , , - Cancer Discovery 2020 cited by 866

  3. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 cited by 1,188

  4. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , - Annals of Oncology 2022 cited by 633

  5. Sarcoma classification by DNA methylation profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schick, Melanie Bewerunge‐Hudler, Till Milde, Olaf Witt, Andreas E. Kulozik, Marcel Kool, Laura Romero‐Pérez, Thomas G. P. Grünewald, Thomas Kirchner, Wolfgang Wick, Michael Platten, Andreas Unterberg, Matthias Uhl, Amir Abdollahi, Jürgen Debus, Burkhard Lehner, Christian Thomas, Martin Hasselblatt, Werner Paulus, Christian Hartmann, Ori Staszewski, Marco Prinz, Jürgen Hench, Stephan Frank, Yvonne M.H. Versleijen‐Jonkers, Marije E. Weidema, Thomas Mentzel, Klaus Griewank, Enrique de Álava, Juan Díaz‐Martín, Miguel Á. Idoate, Kenneth Tou En Chang, Sharon Y. Y. Low, Adrián Cuevas-Bourdier, Michel Mittelbronn, Martin Mynarek, Stefan Rutkowski, Ulrich Schüller, Viktor Mautner, Jens Schittenhelm, Jonathan Serrano, Matija Snuderl, Reinhard Büttner, Thomas Klingebiel, Rolf Buslei, Manfred Gessler, Pieter Wesseling, Winand N.M. Dinjens, Sebastian Brandner, Zane Jaunmuktane, Iben Lyskjær, Peter Schirmacher, Albrecht Stenzinger, Benedikt Brors, Hanno Glimm, Christoph Heining, Òscar M. Tirado, Miguel Sáinz‐Jaspeado, Jaume Mora, Javier Alonso, Xavier García del Muro, Sebastián Morán, Manel Esteller, Jamal Benhamida, Marc Ladanyi, Eva Wardelmann, Cristina R. Antonescu, Adrienne M. Flanagan, Uta Dirksen, Peter Hohenberger and 11 more - Nature Communications 2021 cited by 547

  6. Accurate and efficient detection of gene fusions from RNA sequencing data

    Authors: , , , , , , , , , , , - Genome Research 2021 cited by 524

  7. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R. Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A. Vaporciyan, George R. Blumenschein, Jianjun Zhang, Dwight H. Owen, Collin M. Blakely, Giannis Mountzios, Catherine A. Shu, Christine M. Bestvina, Marina Chiara Garassino, Kristen A. Marrone, Jhanelle E. Gray, Sandip Pravin Patel, Amy L. Cummings, Heather A. Wakelee, Juergen Wolf, Giorgio V. Scagliotti, Federico Cappuzzo, Fabrice Barlési, Pradnya D. Patil, Leylah Drusbosky, Don L. Gibbons, Funda Meric‐Bernstam, J. Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis - Cancer Discovery 2023 cited by 181

  8. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Albrecht Stenzinger, Mark Stewart, Jeff Allen - Journal for ImmunoTherapy of Cancer 2020 cited by 506

  9. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xinjie Xu, Deborah Ritter, Kym Pagel, Kilannin Krysiak, Adrian M. Dubuc, Yassmine Akkari, Xuan Shirley Li, Jennifer Lee, I. P. King, Gordana Raca, Alex H. Wagner, Marylin M. Li, Sharon E. Plon, Shashikant Kulkarni, Obi L. Griffith, Debyani Chakravarty, Dmitriy Sonkin - Genetics in Medicine 2022 cited by 239

  10. Automated sample preparation with SP3 for low‐input clinical proteomics

    Authors: , , , , , - Molecular Systems Biology 2020 cited by 303

  11. Homologous Recombination Deficiency: Concepts, Definitions, and Assays

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Oncologist 2022 cited by 229

  12. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment

    Authors: , , , , , , , , , , , - Radiology 2019 cited by 319

  13. Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marinela Augustin, Walter E. Aulitzky, Peter Hohenberger, Matthias Kroiß, Peter Schirmacher, Richard F. Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens T. Siveke, Christian Brandts, Thomas Kindler, Melanie Boerries, Anna Lena Illert, Nikolas von Bubnoff, Philipp J. Jost, Karsten Spiekermann, Michael Bitzer, Klaus Schulze‐Osthoff, Christof von Kalle, Barbara Klink, Benedikt Brors, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Wilko Weichert, Hanno Glimm, Stefan Fröhling - Cancer Discovery 2021 cited by 285

  14. Morphological and molecular breast cancer profiling through explainable machine learning

    Authors: , , , , , , , , , , , - Nature Machine Intelligence, Nat. Mach. Intell. 2021 cited by 154

  15. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

    Authors: , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2013 cited by 1,040

  16. Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarabjot Pabla, Aparna Pallavajjalla, Gary A. Pestano, Roberto Salgado, Raed Samara, Ethan S. Sokol, Phillip Stafford, Jan Budczies, Albrecht Stenzinger, W Tom, Kenneth C. Valkenburg, X.Z. Wang, Victor Weigman, Mingchao Xie, Qiqi Xie, Ahmet Zehir, Chen Zhao, Yiqiang Zhao, Mark Stewart, Jeff Allen - Annals of Oncology 2021 cited by 182

  17. Tumour mutational burden: clinical utility, challenges and emerging improvements

    Authors: , , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2024 cited by 120

  18. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas F.E. Barth, Martin Wagner, Jan Münch, Sandra Heller, Alexander Kleger - Nature Metabolism 2021 cited by 567

  19. Implementation of precision medicine in healthcare—A European perspective

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Internal Medicine 2023 cited by 71

  20. The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization

    Authors: , , , , , , , , , , , , , , - Cancer Research 2023 cited by 54

  21. The landscape of chromothripsis across adult cancer types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 195

  22. Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)

    Authors: , , , , , , , , , , , , , , , , , , - npj Precision Oncology 2022 cited by 98

  23. Integrative genomic and transcriptomic analysis of leiomyosarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sebastian Bauer, Simon Schimmack, Alexis Ulrich, Gunhild Mechtersheimer, Karsten Rippe, Benedikt Brors, Barbara Hutter, Marcus Renner, Peter Hohenberger, Claudia Scholl, Stefan Fröhling - Nature Communications 2018 cited by 306

  24. Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancers 2020 cited by 128